Abiopharma

🔍 JORDEN DAVID EMERSON (Director)

Company: Nuo Therapeutics, Inc. (AURX)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 125,000 shares of Common Stock at $0.4 per share (Direct)
  Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,071,755.00 | transaction_form_type: 4
• Sold 25,381 shares of Common Stock at $1.97 per share (Direct)
  Date: 2026-01-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,046,374.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 125,000 shares of Option to purchase common stock at $0.4 per share (Derivative)
  Date: 2018-12-31 | Code: M | Expires: 2026-01-01 | Exercise: 2018-12-31 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: Represents a net exercise of outstanding stock options. The reporting person received 99,619 shares of common stock on the net exercise of option to purchase 125,000 shares of common stock. The issuer withheld 25,381 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.97.